Ξανθόπουλος Ανδρέας

Ξανθόπουλος Ανδρέας

Short CV

1. PERSONAL DETAILS

Name: Andreas Xanthopoulos

Date of birth: 05/Mar/1980

Family Status: Married, 3 children

Work: Cardiology Clinic, University General Hospital of Larissa

Telephone: +30 2413502019

Email 1:anxanthopoulos@med.uth.gr

Email 2: andrewvxanth@gmail.com

2. EDUCATION

2.1. Pregraduate training

  • June 1997: Senior High School Diploma, Grade: “Excellent”
  • March 2005: Medical Degree, University of Ioannina, School of Medicine, Ioannina, Greece. Grade: “Very Good”
  • Foreign language: First Certificate in English 1994, Proficiency in English 2013

2.2. Postgraduate training

  • August 2005-January 2007: Rural Medical Training (National Medical Service), Greece.
  • February 2007-February 2008: Military service (Naval Hospital, Salamina, Greece and Naval Hospital, Athens, Greece)
  • June 2008-December 2009: Internal Medicine Residency, Athens, Greece

Internal Medicine Clinic, 1st IKA hospital of Athens

  • May 2010-May 2011: Cardiology Residency, Cardiology Clinic, General Hospital of Kozani, “Mamatsio”
  • June 2011-July 2014: Cardiology Residency, Cardiology Clinic, General Hospital of Athens, “Konstantopouleio”
  • January 2015: Cardiology Specialty Certification

3. PhD DIPLOMA

  • July 2016: University of Thessaly, Medical School, Greece

Thesis: “RDW longitudinal changes in patients with heart failure”, Grade: “Excellent”

4. PROFESSIONAL EXPERIENCE

  • November 2015-October 2016 and December 2016-February 2017: Clinical, Research and Teaching Fellow (University of Thessaly) – Department of Cardiology, University General Hospital of Larissa, Larissa, Greece
  • December 2018-November 2020: Attending Cardiologist, Department of Cardiology, University General Hospital of Larissa, Larissa, Greece
  • November 2020-December 2024: Consultant Cardiologist, Department of Cardiology, University General Hospital of Larissa, Larissa, Greece
  • December 2024-today: Assistant Professor of Cardiology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Department of Cardiology, University General Hospital of Larissa
  • February 2025-today: Visiting Assistant Professor of Cardiology, Medical School, European University Cyprus
  • Head of the Heart Failure Outpatient Clinic (Decision number: 2/6/09-07-2020, Board of Directors, University General Hospital of Larissa), Head of the Amyloidosis Outpatient Clinic (Decision number: 167/2/09-02-2023, Board of Directors, University General Hospital of Larissa)

5. TRAINING-SPECIALIZATION

5.1. Greece

  • January 2015-May 2015: Clinical and Research assistant, 2nd University Cardiology Clinic, Department of Heart Failure, University General Hospital “Attikon”, Athens, Greece

5.2. Abroad

  • September 2013-October 2013: Clinical Fellowship in new echocardiographic techniques, Echocardiography laboratory, Department of Cardiology, Medical University of Vienna, Austria
  • April 2017-October 2018: Research Fellowship in Advanced Heart Failure and Transplantation, Heart and Vascular Institute, Kauffman Center for Heart Failure, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH, USA

6. SCHOLARSHIPS

  • Scholarship from the Hellenic Society of Cardiology for 1 year training abroad.
  • Scholarship from the Kaufman Center for Heart Failure (Cleveland, Ohio, USA)
  • 2018 Heart Failure Society of America Scholarship Program for Advanced Heart Failure and Transplant Fellows

7. MEDICAL SOCIETIES

2012-Currently: European Society of Cardiology (ESC) (ESC ID: 436070)

2015-Currently: Heart Failure Association of ESC (HFA)

2015-Currently: Hellenic Cardiological Society (HCS)

2015-Currently: European Association of Preventive Cardiology (EACPR)

2015- Currently: European Association of Cardiovascular Imaging (EACVI)

2017-Currently: Heart Failure Society of America (HFSA)

2020-Currently: Working Group of Heart Failure, HCS (WG)

2021-Currently: Fellow of the American College of Cardiology (FACC) (Member ID: 3149791)

2021-Currently: Fellow of the Heart Failure Society of America (FHFSA)

2022-Currently: Institute for Cardiovascular Education and Research.

2023-Currently: Fellow of the Heart Failure Association of the European Society of Cardiology (FHFA)

2023-Currently: Fellow of the European Society of Cardiology (FESC-Scientific Excellence)

2024-Currently: Association for Acute CardioVascular Care (ACVC)

8. PUBLICATIONS

1. Xanthopoulos A, Giamouzis G, Tryposkiadis K, Paraskevopoulou E, Paraskevopoulou P, Karagiannis G, Patsilinakos S, Parissis J, Farmakis D, Butler J, Skoularigis J, Triposkiadis F. A simple score for early risk stratification in acute heart failure. Int J Cardiol. 2017 Mar 1;230:248-254. doi: 10.1016/j.ijcard.2016.12.131.
2. Angelidis G, Giamouzis G, Karagiannis G, Butler J, Tsougos I, Valotassiou V, Giannakoulas G, Dimakopoulos N, Xanthopoulos A, Skoularigis J, Triposkiadis F, Georgoulias P. SPECT and PET in ischemic heart failure. Heart Fail Rev. 2017 Mar;22(2):243-261. doi: 10.1007/s10741-017-9594-7.
3. Chamaidi A, Karagiannis G, Christidi A, Parisis C, Koutrakis K, Xanthopoulos A, Skoularigis J, Giamouzis G, Triposkiadis FK. Favorable Pulse Wave Augmentation Indices and Left Ventricular Diastolic Profile in β-Thalassemia Minor. Angiology. 2017 Nov;68(10):899-906. doi: 10.1177/0003319717701658.
4. Xanthopoulos A, Giamouzis G, Melidonis A, Kitai T, Paraskevopoulou E, Paraskevopoulou P, Patsilinakos S, Triposkiadis F, Skoularigis J. Red blood cell distribution width as a prognostic marker in patients with heart failure and diabetes mellitus. Cardiovasc Diabetol. 2017 Jul 6;16(1):81. doi: 10.1186/s12933-017-0563-1.
5. Xanthopoulos A, Giamouzis G, Alexopoulos N, Kitai T, Triposkiadis F, Skoularigis J. Lipomatous Hypertrophy of the Interatrial Septum: A Case Report and Review of the Literature. CASE (Phila). 2017 Aug 23;1(5):182-189. doi: 10.1016/j.case.2017.06.005.
6. Xanthopoulos A, Skoularigis J. Diagnosis of acute pericarditis. ESC E-journal of Cardiology Practice. 2017;15(15) (https://www.escardio.org/Journals/E-Journal-of-Cardiology-Practice/Volume-15/Diagnosis-of-acute-pericarditis)
7. Starling RC, Xanthopoulos A. Are Outcomes Related to Left Ventricular Assist Device Center Volume?: Too Complex to Answer. JACC Heart Fail. 2017 Oct;5(10):700-702. doi: 10.1016/j.jchf.2017.07.003.
8. Krittanawong C, Xanthopoulos A, Kitai T, Branis N, Zhang H, Kukin M.

DPP-4 inhibitors and heart failure: a potential role for pharmacogenomics.

Heart Fail Rev. 2018 May;23(3):355-361. doi: 10.1007/s10741-017-9655-y.
9. Xanthopoulos A, Tryposkiadis K, Giamouzis G, Konstantinou D, Giannakoulas G, Karvounis H, Kattan MW, Skoularigis J, Parissis J, Starling RC, Triposkiadis F.

Larissa Heart Failure Risk Score: a proposed simple score for risk stratification in chronic heart failure. Eur J Heart Fail. 2018 Mar;20(3):614-616. doi: 10.1002/ejhf.1132.
10. Xanthopoulos A, Triposkiadis F, Starling RC. Heart failure with preserved ejection fraction: Classification based upon phenotype is essential for diagnosis and treatment. Trends Cardiovasc Med. 2018 Aug;28(6):392-400. doi: 10.1016/j.tcm.2018.01.001
11. Xanthopoulos A, Starling RC, Triposkiadis F.  Mitral valve stenosis: still a clinical challenge? Cardiology. 2018;140(1):45-46. doi: 10.1159/000487664.

12. Kitai T, Tang WHW, Xanthopoulos A, Murai R, Yamane T, Kim K, Oishi S, Akiyama E, Suzuki S, Yamamoto M, Kida K, Okumura T, Kaji S, Furukawa Y, Matsue Y. Impact of early treatment with intravenous vasodilators and blood pressure reduction in acute heart failure. Open Heart. 2018 Jul 11;5(2):e000845. doi: 10.1136/openhrt-2018-000845

13. Miyamoto Τ, Karimov JH, Xanthopoulos A, Starling RC, Fukamachi K. Large animal models to test mechanical circulatory support devices. Drug Discovery Today: Disease Models. 2017;24: 47-53. doi: 10.1016/j.ddmod.2018.06.003

14. Xanthopoulos A, Starling RC, Kitai T, Triposkiadis F. Heart Failure and Liver Disease: Cardiohepatic Interactions. JACC Heart Fail. 2019 Feb;7(2):87-97. doi: 10.1016/j.jchf.2018.10.007.

15. Kittipibul V, Xanthopoulos A, Hurst TE, Fukamachi K, Blackstone EH, Soltesz E, Starling RC. Clinical Courses of HeartMate II Left Ventricular Assist Device Thrombosis. ASAIO J. 2020 Feb;66(2):153-159. doi:10.1097/MAT.0000000000000952.

16. Arfaras-Melainis A, Polyzogopoulou E, Triposkiadis F, Xanthopoulos A, Ikonomidis I, Mebazaa A, Parissis J. Heart failure and sepsis: practical recommendations for the optimal management. Heart Fail Rev. 2020 Mar;25(2):183-194. doi: 10.1007/s10741-019-09816-y.

17. Xanthopoulos A, Papamichalis M, Zajichek A, Milinovich A, Kattan MW, Skoularigis J, Starling RC, Triposkiadis F. In-hospital red blood cell distribution width change in patients with heart failure. Eur J Heart Fail. 2019 Dec;21(12):1659-1661. doi: 10.1002/ejhf.1546.

18. Hurst TE, Xanthopoulos Α, Ehrlinger J, Rajeswaran J, Pande A, Thuita L, Smedira NG, Moazami N, Blackstone EH, Randall C. Starling RC. Dynamic Prediction of Left Ventricular Assist Device Pump Thrombosis Based on Lactate Dehydrogenase Trends. ESC Heart Fail. 2019 Oct;6(5):1005-1014. doi: 10.1002/ehf2.12473.

19. Triposkiadis F, Xanthopoulos A, Butler J. Cardiovascular Aging and Heart Failure. J Am Coll Cardiol. 2019 Aug 13;74(6):804-813. doi: 10.1016/j.jacc.2019.06.053.

20. Kitai T, Okamoto T, Miyakoshi C, Niikawa H, Alvarez PA, Xanthopoulos A,

McCurry K. R. Impact of Combined Heart and Lung Transplantation on Bronchiolitis Obliterans Syndrome, Cardiac Allograft Vasculopathy and Long-Term Survival. J Heart Lung Transplant. 2019 Nov;38(11):1170-1177. doi: 10.1016/j.healun.2019.06.004.

21. Tsaknakis K, Xanthopoulos A, Papamichalis M, Chamaidi A, Tsaknakis T, Skoularigis J, Triposkiadis F. Relationship of CHA2DS2-VASc score to left atrial volume and arterial stiffness in patients with atrial fibrillation. Hellenic J Cardiol. Jan-Feb 2020;61(1):54-56. doi: 10.1016/j.hjc.2019.07.002.

22. Papamichalis M, Xanthopoulos A, Papamichalis P, Skoularigis J, Triposkiadis F. Adult Congenital Heart Disease with Pulmonary Arterial Hypertension: Mechanisms and Management. Heart Fail Rev. 2020 Sep;25(5):773-794. doi: 10.1007/s10741-019-09847-5.

23. Papagiannis D, Rachiotis G, Xanthopoulos A, Simou A, Zilidis C, Triposkiadis F. Immunization Practices in High-Level Football Players in Greece. Occup Med (Lond)

. 2020 May 27;70(3):200-202. doi: 10.1093/occmed/kqaa004.

24. Triposkiadis F, Xanthopoulos A, Parissis J. Risk in Atrial Fibrillation: Left Atrial Function Matters. Eur J Heart Fail. 2019 Dec;21(12):1584-1585. doi: 10.1002/ejhf.1637

25. Economou D, Xanthopoulos A, Papamichalis M, Chamaidi A, Dimos A, Tavoularis D, Skoularigis J, Triposkiadis F. Left Atrial Systolic Function in Acute Coronary Syndromes. Hellenic J Cardiol. Jul-Aug 2020;61(4):291-292. doi: 10.1016/j.hjc.2019.10.005.

26. Xanthopoulos Α, Butler J, Parissis J, Polyzogopoulou E, Skoularigis J, Triposkiadis F. Acutely Decompensated Versus Acute Heart Failure: Two Different Entities. Heart Fail Rev. 2020 Nov;25(6):907-916. doi: 10.1007/s10741-019-09894-y.

27. Dimos A, Xanthopoulos A, Papamichalis M, Bourazana A, Tavoularis D, Skoularigis J, Triposkiadis F. Sudden Arrhythmic Death at the Higher End of the Heart Failure Spectrum. Angiology. 2020 May;71(5):389-396. doi:10.1177/0003319719896475.

28. Kitai T, Xanthopoulos A. Contemporary Management of Acute Decompensated Heart Failure and Cardiogenic Shock. Heart Fail Clin. 2020 Apr;16(2):221-230. doi: 10.1016/j.hfc.2019.12.005.

29. Kitai T*, Xanthopoulos A*, Tang W.H.W, Miyakoshi C, Toyoda T, Kim K, Kaji S, Furukawa Y, Oishi S, Akiyama E, Suzuki S, Yamamoto M, Kida K, Okumura T, Skoularigis J, Triposkiadis F, Matsue Y. Validation of the Larissa Heart Failure Risk Score for risk stratification in acute heart failure. Int J Cardiol. 2020 May 15;307:119-124. doi: 10.1016/j.ijcard.2019.12.051.

* Authors contributed equally

30. Iakovis Ν, Xanthopoulos Α, Chamaidi Α, Papamichalis Μ, Dimos Α, Triposkiadis F, Skoularigis J. Recurrent acute coronary syndromes in a patient with idiopathic thrombocytopenic purpura. Case Rep Cardiol. 2020 Mar 12;2020:6738348. doi: 10.1155/2020/6738348

31. Triposkiadis F, Xanthopoulos A, Butler J. From PARADIGM to PARAGON:

Further Evidence Supporting Continuous Heart Failure Spectrum. Eur J Heart Fail

. 2020 Sep;22(9):1536-1539. doi: 10.1002/ejhf.1837.

32. Bourazana A, Xanthopoulos A, Skoularigis J, Triposkiadis F. Preoperative antiplatelet therapy and bleeding risk in patients undergoing off-pump coronary artery bypass grafting: A fine balance. Angiology. 2020 Sep;71(8):701-703. doi: 10.1177/0003319720925973.

33. Xanthopoulos Α, Tryposkiadis Κ, Triposkiadis F, Fukamachi K, Soltesz EG, Young JB, Wolski K, Blackstone EH, Starling RC. Postimplant Phosphodiesterase Type 5 Inhibitors Use Is Associated With Lower Rates of Thrombotic Events After Left Ventricular Assist Device Implantation. J Am Heart Assoc. 2020 Jul 21;9(14):e015897. doi: 10.1161/JAHA.119.015897.

34. Xanthopoulos A, Dimos A, Giamouzis G, Bourazana A , Zagouras A, Papamichalis M, Kitai T, Skoularigis J, Triposkiadis F. Coexisting Morbidities in Heart Failure: no Robust Interaction with the Left Ventricular Ejection Fraction. Curr Heart Fail Rep

. 2020 Aug;17(4):133-144. doi: 10.1007/s11897-020-00461-3.

35. Xanthopoulos A, Triposkiadis F, Starling R. Care for Patients with ventricular assist devices in the COVID-19 era. Eur J Heart Fail. 2020 Jun;22(6):937-940. doi: 10.1002/ejhf.1907.

36. Triposkiadis F, Xanthopoulos A, Parissis J, Butler J, Farmakis D. Pathogenesis of Chronic Heart Failure: Cardiovascular Aging, Risk Factors, Comorbidities, and Disease Modifiers. Heart Fail Rev. 2022 Jan;27(1):337-344. doi: 10.1007/s10741-020-09987-z.

37. Giamouzis G, Xanthopoulos A, Papamichalis M, Chroub-Papavaiou A-N, Pantziou A, Simou A, Dimos A, Bourazana A, Skoularigis J, Triposkiadis F. Relative contribution of risk factors/comorbidities in the pathogenesis of heart failure: interaction with left ventricular ejection fraction. ESC Heart Fail. 2020. ESC Heart Fail. 2020 Dec; 7(6): 4399–4403. doi: 10.1002/ehf2.12975

38. Dimos A, Xanthopoulos A, Georgousi A, Eleftheriou M, PhD4, Ekmektzoglou K, Iacovidou N, Kouskouni E, Papagiannis D, Skoularigis J, Triposkiadis F, Chalkias A, Xanthos T. Hellenic army recruits and change in tobacco use habits after entering the military life. Hellenic J Cardiol. 2020 Aug 23;S1109-9666(20)30186-X. doi: 10.1016/j.hjc.2020.08.004

39. Triposkiadis F, Starling RC, Xanthopoulos A, Butler J, Boudoulas H.

Renin-Angiotensin-System Inhibition in the Context of Corona Virus Disease-19: Experimental Evidence, Observational Studies, Clinical Implications. Heart Fail Rev. 2021 Mar;26(2):381-389. doi: 10.1007/s10741-020-10022-4.

40. Triposkiadis F, Boudoulas KD, Xanthopoulos A, Boudoulas H. Fallacies in Medical Practice: Renin-Angiotensin-Aldosterone System Inhibition and COVID-19 as a Paradigm. Hellenic J Cardiol. 2021 May-Jun;62(3):185-189. doi: 10.1016/j.hjc.2020.10.008.

41. Triposkiadis F, Starling RC, Xanthopoulos A, Butler J, Boudoulas H. The Counter Regulatory Axis of the Lung Renin-Angiotensin System in Severe COVID-19: Physiopathology and Clinical Implications. Heart Lung Circ. 2021 Jun;30(6):786-794. doi: 10.1016/j.hlc.2020.11.008.

42. Farmakis D, Xanthopoulos A, Triposkiadis F. A critical appraisal of the pharmacological management of stable angina. Hellenic J Cardiol. Mar-Apr 2021;62(2):135-138. doi: 10.1016/j.hjc.2021.01.012.

43. Papamichalis M, Xanthopoulos A, Triposkiadis F. Adult Congenital Heart Disease Related Pulmonary Arterial Hypertension: Novel Definitions and Therapeutic Trends. Int J Integr Cardiol. 2021;3:1.117. doi: https://doi.org/10.47275/2690-862X-117. https://www.scholarsliterature.com/journals/international-journal-of-integrative-cardiology/issues/3/1

44. Spiliopoulos K, Anyfantakis Z-A, Diminikos I, Xanthopoulos A, Magouliotis D, Skoularigis J, Triposkiadis F. Acute myocardial infarction not attributed to coronary artery disease: a seldom initial presentation of a left ventricular myxoma. Clin Case Rep. 2021 May 4;9(5):e04029. doi: 10.1002/ccr3.4029.

45. Triposkiadis F, Xanthopoulos A, Starling RC. Medical Treatment of Heart Failure:

Ignore the Ejection Fraction and Treat All? J Card Fail. 2021 Aug;27(8):907-909. doi: 10.1016/j.cardfail.2021.02.015.

46. Sdogkos E, Xanthopoulos A, Giamouzis G, Skoularigis J, Triposkiadis F, Vogiatzis I. Diagnosis of coronary artery disease: potential complications of imaging techniques. Acta Cardiol. 2021 Apr 16;1-4. doi: 10.1080/00015385.2021.1911467.

47. Dimos A, Xanthopoulos A, Bismpos D, Triposkiadis F, Skoularigis J. Delayed Acute Coronary Syndrome Caused by Multiple Bee Stings: A Rare Case of Kounis Syndrome. Cureus. 2021 Mar 26;13(3):e14120. doi: 10.7759/cureus.14120.

48. Triposkiadis F, Xanthopoulos A, Starling RC, Iliodromitis E. Obesity, Inflammation, and Heart Failure: Links and Misconceptions. Heart Fail Rev. 2022 Mar;27(2):407-418. doi: 10.1007/s10741-021-10103-y.

49. Giamouzis G, Dimos A, Xanthopoulos A, Skoularigis J, Triposkiadis F.

Left Ventricular Hypertrophy and Sudden Cardiac Death. Heart Fail Rev. 2022 Mar;27(2):711-724. doi: 10.1007/s10741-021-10134-5.

50. Kitai T, Shimogai T, Tang WH, Iwata K, Xanthopoulos A, Otsuka S, Nakada F, Yokohama R, Kamiya K, Saito H, Saito K, Maekawa E, Konishi M, Ogasawara Y, Jujo K, Wada H, Kasai T, Momomura S, Krittanawong C, Skoularigis J, Triposkiadis F, Kagiyama N, Furukawa Y, Matsue Y. Short physical performance battery vs. 6-minute walking test in hospitalized elderly patients with heart failure. Eur Heart J-Open. 2021;1(1):1-8. doi:10.1093/ehjopen/oeab006

51. Kyriakopoulos V, Xanthopoulos A, Papamichalis M, Skoularigkis S, Tzavara C, Papadakis E, Patsilinakos S, Triposkiadis F, Skoularigis J. Patent hemostasis of radial artery: Comparison of two methods. World J Cardiol. 2021 Oct 26;13(10):574-584. doi: 10.4330/wjc.v13.i10.574.

52. Dimos A, Xanthopoulos A, Triposkiadis F. Complete atelectasis: An endotracheal tube displacement complication. Oxf Med Case Reports. 2021 Sep13;2021(9):omab085. doi: 10.1093/omcr/omab085

 

53. Xanthopoulos A, Tryposkiadis K, Dimos A, Bourazana A, Zagouras A, Iakovis N, Papamichalis M, Giamouzis G, Vassilopoulos G, Skoularigis J, Triposkiadis F. Red Blood Cell Distribution Width in Elderly Hospitalized Patients with Cardiovascular Disease. World J Cardiol. 2021 Sep 26;13(9):503-513. doi: 10.4330/wjc.v13.i9.503.

54. Triposkiadis F, Xanthopoulos A, Bargiota A, Kitai T, Katsiki N, Farmakis D, Skoularigis J, Starling RC, Iliodromitis E. Diabetes mellitus and heart failure. J Clin Med. 2021 Aug 19;10(16):3682. doi: 10.3390/jcm10163682.

55. Triposkiadis F, Xanthopoulos A, Giamouzis G, Boudoulas KD, Starling RC, Skoularigis J, Boudoulas H, Iliodromitis E. ACE-2, the Counter-regulatory Renin-Angiotensin System Axis and Covid-19 Severity. J Clin Med. 2021 Aug 29;10(17):3885. doi: 10.3390/jcm10173885.

56. Xanthopoulos A, Wolski K, Wang Q, Blackstone EH, Randhawa VK, Soltesz EG,

Young JB, Nissen SE, Estep JD, Triposkiadis F, Starling RC. Post Implant Phosphodiesterase Type 5 Inhibitor Use in Centrifugal Flow Left Ventricular Assist Devices. JACC Heart Fail. 2022 Feb;10(2):89-100. doi: 10.1016/j.jchf.2021.09.008

57. Xanthopoulos A, Tryposkiadis K, Giamouzis G, Dimos A, Bourazana A, Papamichalis M, Zagouras A, Iakovis N, Kitai T, Skoularigis J, Starling RC, Triposkiadis F. Coexisting Morbidity Burden in Hospitalized Elderly Patients with New-Onset Heart Failure vs. Acutely Decompensated Chronic Heart Failure. Angiology. 2022 Jul;73(6):520-527. doi: 10.1177/00033197211062661.

58. Triposkiadis F, Xanthopoulos A, Iliodromitis E. EMPEROR Preserved: Searching for Identity? N Engl J Med. 2022 May 26;386(21):e57. doi: 10.1056/NEJMc2118470

59. Simou A, Xanthopoulos A, Giamouzis G, Papagiannis D, Dimos A, Economou D, Skoularigis J, Triposkiadis F. Coexisting morbidity burden in elderly hospitalized patients with and without heart failure. Hellenic J Cardiology. 2022 May-Jun;65:53-55. doi: 10.1016/j.hjc.2022.02.002.

60. Bourazana A, Giamouzis G, Skoularigis J, Triposkiadis F, Xanthopoulos A. Glucose Lowering Does not Necessarily Reduce Cardiovascular Risk in Type 2 Diabetes. World J Cardiol. 2022 Apr 26;14(4):266-270. doi: 10.4330/wjc.v14.i4.266.

61. Xanthopoulos A, Giamouzis G, Dimos A, Skoularigki E, Starling RC, MPH2, Skoularigis J, Triposkiadis F. Red Blood Cell Distribution Width in Heart Failure: Patho-physiology, Prognostic Role, Controversies and Dilemmas. J Clin Med. 2022 Apr; 11(7): 1951. doi: 10.3390/jcm11071951

62. Triposkiadis F, Xanthopoulos A, Skoularigis J, Starling RC. Therapeutic Augmentation of NO-sGC-cGMP Signalling: Lessons Learned from Pulmonary Arterial Hypertension and Heart Failure. Heart Fail Reviews. 2022 Nov;27(6):1991-2003. doi: 10.1007/s10741-022-10239-5.

63. Varsamo A, Xanthopoulos A, Giamouzis G, Davos C, Stavrou V, Batalik L, Kapreli E, Gourgoulianis K, Skoularigis J, Pepera, Garyfallia. Efficacy, Efficiency and Safety of a Cardiac Telerehabilitation Program Using Wearable Sensors (TELE WEAR): Rationale and Design of a Supervised Randomized Controlled Clinical Trial. BMJ Open. 2022 Jun 23;12(6):e059945. doi: 10.1136/bmjopen-2021-059945.

64. Kitai T, Xanthopoulos A, Nakagawa S, Ishii N, Triposkiadis F, Izumi C. Contemporary Diagnosis and Management of Hypertrophic Cardiomyopathy: The Role of Echocardiography and Multimodality Imaging. J Cardiovasc Dev Dis. 2022 May 25;9(6):169. doi: 10.3390/jcdd9060169.

65. Starling RC, Xanthopoulos A, Nissen SE, Triposkiadis F. Reduction of Adverse Events with Phosphodiesterase 5 Inhibitors post LVAD Implantation: It is time for a Randomized Trial? J Card Fail. 2022 Jun 8;S1071-9164(22)00546-2. doi: 10.1016/j.cardfail.2022.06.001.

66. Triposkiadis F, Xanthopoulos A, Boudoulas KD, Giamouzis G, Boudoulas H, Skoularigis J. The Interventricular Septum: Structure, Function, Dysfunction, and Diseases. J Clin Med. 2022 Jun 6;11(11):3227. doi: 10.3390/jcm11113227.

67. Karamichalakis N, Xanthopoulos A, Triposkiadis F, Paraskevaidis I, Tsougos E. Reshaping Treatment of HFpEF. J Clin Med. 2022 Jun 27;11(13):3706. doi: 10.3390/jcm11133706.

68. Xanthopoulos A, Giamouzis G, Skoularigis J, Triposkiadis F. Heart Failure With Reduced, Mildly Reduced or Preserved Left Ventricular Ejection Fraction: Has Reasoning Been Lost? World J Cardiol. 2022 Jul 26;14(7):438-445. doi: 10.4330/wjc.v14.i7.438.

69. Pantsios C, Anyfantakis Z-A, Xanthopoulos A, Leventis I, Skoularigkis S, Dimos A, Angeliki Bourazana A, Papamichalis M, Giamouzis G, Triposkiadis F, Skoularigis J. Acute myopericarditis after the second dose of mRNA COVID-19 vaccine mimicking acute coronary syndrome: A case report. Case Rep Cardiol. 2022 Aug 9;2022:1600734. doi: 10.1155/2022/1600734.

70. Xanthopoulos A, Bourazana A, Giamouzis G, Skoularigki E, Dimos A, Zagouras A, Papamichalis M, Leventis I, Magouliotis D, Triposkiadis F, Skoularigis J. COVID-19 and the heart. World J Clin Cases. 2022; 10(28): 9970-9984. doi: 10.12998/wjcc.v10.i28.9970

71. Triposkiadis F, Giamouzis G, Kitai T, Skoularigis J, Starling RC, Xanthopoulos A. A Holistic View of Advanced Heart Failure. Life (Basel). 2022 Aug 24;12(9):1298. doi: 10.3390/life12091298.

72. Katsiadas N*, Xanthopoulos A*, Giamouzis G, Skoularigkis S, Skopeliti N, Moustaferi E, Ioannidis I, Patsilinakos S, Triposkiadis F, Skoularigis J. The Effect of SGLT2i Administration on Red Blood Cell Distribution Width in Patients with Heart Failure and Type 2 Diabetes Mellitus: A Randomized Study. Frontiers in Cardiov Medicine. 2022; 9: 984092. doi: 10.3389/fcvm.2022.984092

* contributed equally and should be considered both as first authors

73. Konstantinou C, Xanthopoulos A, Tsaras K, Skoularigis J, Triposkiadis F, Papagiannis D. Vaccination coverage against human papillomavirus in female students in Cyprus. Cureus. 2022 Sep 8;14(9):e28936. doi: 10.7759/cureus.28936.

74. Dimos A, Xanthopoulos A, Giamouzis G, Kitai T, Economou D, Skoularigis J, Triposkiadis F. The “Vulnerable” Post Hospital Discharge Period in Acutely Decompensated Chronic vs. De-Novo Heart Failure: Outcome Prediction Using The Larissa Heart Failure Risk Score. Hellenic J Cardiology. 2022 Oct 2;S1109-9666(22)00147-6. doi: 10.1016/j.hjc.2022.09.014.

75. Xanthopoulos A, Magouliotis DE, Triposkiadis K, Zotos P-A, Spiliopoulos K, Athanasiou T, Giamouzis G, Skoularigis J, Starling RC, Triposkiadis F. Post Implant Phosphodiesterase 5 Inhibitors in Patients with Left Ventricular Assist Device: A Systematic Review and Meta-analysis. J Clin Med. 2022 Oct 11;11(20):5988. doi: 10.3390/jcm11205988.

76. Triposkiadis F, Giamouzis G, Skoularigis J, Xanthopoulos A. HFpEF: A Distinct Heart Failure Phenotype? World Journal Clin Cases. 2022 Nov 16;10(32):12052-12055. doi: 10.12998/wjcc.v10.i32.12052.

77. Magouliotis DE, Fergadi MP, Zotos PA, Rad AA, Xanthopoulos A, Bareka M, Spiliopoulos K, Athanasiou T. Differences in long-term survival outcomes after coronary artery bypass grafting using single vs multiple arterial grafts: A meta-analysis with reconstructed time-to-event data and subgroup analyses. Gen Thorac Cardiovasc Surg. 2022 Nov 17. doi: 10.1007/s11748-022-01891-7.

78. Xanthopoulos A, Skoularigis J, Triposkiadis F. The Neurohormonal Overactivity Syndrome in Heart Failure. Life (Basel). 2023 Jan 16;13(1):250. doi: 10.3390/life13010250.

79. Spiliopoulos K, Magouliotis D, Xanthopoulos A, Salemis NS. Infective Endocarditis: Controversies and Convictions in the Surgical Treatment. Braz J Cardiovasc Surg 2023 Nov-Dec;38(6):e20230014. doi: 10.21470/1678-9741-2023-0014

80. Doulamis IP, Wu B, Akbar AF, Xanthopoulos A, Androulakis E, Briasoulis A. Pacemaker Implantation following Heart Transplantation: Analysis of a Nation-Wide Database. J Clin Med. 2023 Feb 17;12(4):1604. doi: 10.3390/jcm12041604.

81. Xanthopoulos Α, Christofidis C, Pantsios C, Magouliotis D, Bourazana A, Leventis I, Skopeliti N, Skoularigki E, Briasoulis A, Giamouzis G, Triposkiadis F and Skoularigis J. The Prognostic Role of Spot Urinary Sodium and Chloride in a Cohort of Hospitalized Advanced Heart Failure Patients: A Pilot Study. Life (Basel). 2023 Mar 5;13(3):698. doi: 10.3390/life13030698.

82. Giamouzis G, Xanthopoulos A, Boudoulas KD, Karagiannis G, Skoularigis J, Triposkiadis F. Novel and emerging therapies in heart failure. Frontiers in Cardiov Medicine. 2023; 10: 1179352. doi: 10.3389/fcvm.2023.1179352

83. Triposkiadis F, Xanthopoulos A, Lampropoulos K, Briasoulis A, Sarafidis P, Skoularigis J, Boudoulas H. Aortic Stiffness: A Major Risk Factor for Multimorbidity in the Elderly. J Clin Med. 2023 Mar 16;12(6):2321. doi: 10.3390/jcm12062321.

84. Karamolegkou AP, Fergadi MP, Magouliotis DE, Samara AA, Tatsios E, Xanthopoulos A, Pourzitaki,C, Walker D, Zacharoulis D. Validation of the Surgical Outcome Risk Tool (SORT) and SORT v2 for predicting postoperative mortality in patients with pancreatic cancer undergoing surgery. J Clin Med. 2023 Mar 16;12(6):2327. doi: 10.3390/jcm12062327.

85. Lionakis N, Briasoulis A, Zouganeli V, Koutoulakis E, Kalpakos D, Xanthopoulos A, Skoularigis J, Kourek C. Coronary artery aneurysms: Comprehensive review and a case report of a left main coronary artery aneurysm. Curr Probl Cardiol. 2023 Mar 15;101700. doi: 10.1016/j.cpcardiol.2023.101700.

86. Papamichail A, Androulakis E, Xanthopoulos A, Briasoulis A. Effect of Training Load on Post-Exercise Cardiac Biomarkers in Healthy Children and Adolescents: A Systematic Review of the Existing Literature. J Clin Med. 2023 Mar 21;12(6):2419. doi: 10.3390/jcm12062419.

87. Chrysakis N, Xanthopoulos A, Magouliotis D, Starling RC, Drakos SG, Triposkiadis F, Skoularigis J. Myocardial recovery. Diagnostics (Basel). 2023 Apr 21;13(8):1504. doi: 10.3390/diagnostics13081504.

88. Paraskevaidis I, Xanthopoulos A, Karamichalakis N, Triposkiadis F, Tsougos E. Medical treatment in heart failure with reduced ejection fraction: A proposed algorithm based on the patient’s electrolytes and congestion status. Med Sci (Basel). 2023 May 24;11(2):38. doi: 10.3390/medsci11020038.

89. Xanthopoulos A, Bourazana A, Matsue Y, Fujimoto Y; Oishi S, Akiyama E, Suzuki S, Yamamoto M, Kida K, Okumura T, Giamouzis G, Skoularigis J, Triposkiadis F, Kitai T. Larissa Heart Failure Risk Score and Mode of Death in Acute Heart Failure: Insights From REALITY-AHF. J Clin Med. 2023 May 28;12(11):3722. doi: 10.3390/jcm12113722.

90. Briasoulis A, Bampatsias D, Papamichail A, Kuno T, Skoularigis J, Xanthopoulos A, Triposkiadis F. Invasive and Non-Invasive Diagnostic Pathways in the Diagnosis of

Cardiac Amyloidosis. J Cardiovasc Dev Dis. 2023 Jun 11;10(6):256.

doi: 10.3390/jcdd10060256.

91. Xanthopoulos A, Briasoulis A. Cardiovascular Toxicity Related to Cancer Treatment. J Cardiovasc Dev Dis. 2023 Jun 14;10(6):259. doi: 10.3390/jcdd10060259.

92. Magouliotis DE, Xanthopoulos A, Zotos P-A, Rad AA, Tatsios E, Bareka M,

Briasoulis A, Triposkiadis F, Skoularigis J, Athanasiou T. The emerging role of “Failure to Rescue” as the primary quality metric for cardiovascular surgery and critical care. J Clin Med. 2023 Jul 24;12(14):4876. doi: 10.3390/jcm12144876.

93. Triposkiadis F, Sarafidis P, Briasoulis A, Magouliotis DE, Athanasiou T, Skoularigis J, Xanthopoulos A. Hypertensive Heart Failure. J Clin Med. 2023 Aug 2;12(15):5090. doi: 10.3390/jcm12155090.

94. Briasoulis A, Kourek C, Papamichail A, Loritis K, Bampatsias D, Repasos E, Xanthopoulos A, Tsougos E, Paraskevaidis I. Arrhythmias in patients with cardiac amyloidosis: A comprehensive review on clinical management and devices J Cardiovasc Dev Dis. 2023 Aug 5;10(8):337. doi: 10.3390/jcdd10080337.

95. Xanthopoulos A, Katsiadas N, Skoularigkis S, Magouliotis DE, Skopeliti N, Patsilinakos S, Briasoulis A, Triposkiadis F, Skoularigis J. Association Between Dapagliflozin, Cardiac Biomarkers, and Cardiac Remodeling in patients with Diabetes Mellitus and Heart Failure. Life (Basel). 2023 Aug 20;13(8):1778. doi: 10.3390/life13081778.

96. Iakovis N, Ikonomidis I, Andreadou I, Xanthopoulos A, Chamaidi A, Chrysakis N, Giamouzis G, Skoularigis J, Tseti I, Triposkiadis F. The Short-Term Effect of Olive Oil Extract Enriched with Hydroxytyrosol on Cardiovascular Function. J Med Food. 2023 Dec;26(12):939-942. doi: 10.1089/jmf.2023.0129.

97. Triposkiadis F, Briasoulis A, Kitai T, Magouliotis D, Athanasiou T, Skoularigis J, Xanthopoulos A. The Sympathetic Nervous System in Heart Failure Revisited. Heart Fail Rev. 2023 Sep 14. doi: 10.1007/s10741-023-10345-y.

98. Spiliopoulos K, Fludas I, Xanthopoulos A, Magouliotis D, Zotos P-A, Salemis NS,

Athanasiou T, Schmid F-X. New challenges for the surgeon in the modern era of transcatheter aortic valves: early single center experience of their surgical explantation. Hellenic J Cardiol. 2023 Nov-Dec:74:77-80. doi: 10.1016/j.hjc.2023.09.007.

99. Sdogkos E, Iliodromitis K, Xanthopoulos A, Triposkiadis F, Skoularigis J, Bogossian H, Vogiatzis I. Conduction System Pacing: How far are we from the “electrical” bypass? Heart Fail Rev. 2024 Jan;29(1):45-63. doi: 10.1007/s10741-023-10349-8.

100. Suzuki S, Kitai T, Skoularigis J, Spiliopoulos K, Xanthopoulos A. Catheter Ablation for Atrial Fibrillation in Patients with Heart Failure: Current Evidence and Future Opportunities. J Pers Med. 2023 Sep 18;13(9):1394. doi: 10.3390/jpm13091394.

101. Paraskevaidis I, Xanthopoulos A, Tsougos E, Triposkiadis F. Human Gut Microbiome in Heart Failure: Trying to Unmask an Emerging Organ. Biomedicines. 2023 Sep 19;11(9):2574. doi: 10.3390/biomedicines11092574.

102. Faitatzidou D, Karagiannidis AG, Theodorakopoulou M, Xanthopoulos A, Triposkiadis F, Sarafidis P. Autonomic nervous system dysfunction in peritoneal dialysis patients: an underrecognized cardiovascular risk factor? Am J Nephrol. 2024;55(1):37-55. doi: 10.1159/000534318.

103. Xanthopoulos A, Papamichail A, Briasoulis A, Loritis K, Bourazana A, Magouliotis DE, Sarafidis P, Stefanidis I, Skoularigis J, Triposkiadis F. Heart Failure in Patients with Chronic Kidney Disease. J Clin Med. 2023 Sep 21;12(18):6105. doi: 10.3390/jcm12186105.

104. Paraskevaidis I, Xanthopoulos A, Triposkiadis F, Tsougos E. In search for the right track; From definition to Diagnosis and Treatment for Heart failure. Annals of Clinical and Medical Case Reports. 2023 Oct 2; V11(7):1-6. doi: https://doi.org/10.47829/ACMCR.2023.11701

105. Kurashima S, Kitai T, Xanthopoulos A, Skoularigis J, Triposkiadis F; Izumi C. Diagnosis of cardiac sarcoidosis: histological evidence vs. imaging. Expert Rev Cardiovasc Ther. 2023 Jul-Dec;21(10):693-702. doi: 10.1080/14779072.2023.2266367.

106. Triposkiadis F, Briasoulis A, Sarafidis P, Magouliotis D, Athanasiou T, Paraskevaidis I, Skoularigis J, Xanthopoulos A. The Sympathetic Nervous System in Hypertensive Heart Failure with Preserved LVEF. J Clin Med. 2023 Oct 12;12(20):6486. doi: 10.3390/jcm12206486.

107. Manetas-Stavrakakis N, Sotiropoulou IM, Paraskevas T, Stavrakaki SM, Bampatsias D, Xanthopoulos A, Papageorgiou N, Briasoulis A. Accuracy of Artificial Intelligence-Based Technologies for the Diagnosis of Atrial Fibrillation: A Systematic Review and Meta-Analysis. J Clin Med. 2023 Oct 17;12(20):6576. doi: 10.3390/jcm12206576.

108. Kourek C, Briasoulis A, Karatzanos E, Zouganeli V, Psarra K, Pratikaki M, Alevra-Prokopiou A, Skoularigis J, Xanthopoulos A, Nanas S, Dimopoulos S. The effects of a cardiac rehabilitation program on endothelial progenitor cells and inflammatory profile in patients with chronic heart failure of different severity. J Clin Med. 2023 Oct 18;12(20):6592. doi: 10.3390/jcm12206592.

109. Kourek C, Briasoulis A, Giamouzis G, Skoularigis J, Xanthopoulos A. Lyophilized recombinant human brain natriuretic peptide: A promising therapy in patients with chronic heart failure. World J Clin Cases. 2023 Dec 26;11(36):8603-8605. doi: 10.12998/wjcc.v11.i36.8603.

110. Xanthopoulos A, Skoularigis J, Briasoulis A, Magouliotis DE, Zajichek A, Milinovich A, Kattan MW, Triposkiadis F, Starling RC. Analysis of the Larissa Heart Failure Risk Score: Predictive Value in 9,207 Patients Hospitalized for Heart Failure from a Single Center. J Pers Med. 2023 Dec 17;13(12):1721. doi: 10.3390/jpm13121721.

111. Spiliopoulos K, Magouliotis D, Angelis I, Skoularigis J, Kemkes BM, Salemis NS, Athanasiou T, Gansera B, Xanthopoulos A. Concomitant valve replacement and coronary artery bypass grafting surgery: Lessons from the past, guidance for the future? A mortality analysis in 294 patients. J Clin Med. 2023 Dec 30;13(1):238. doi: 10.3390/jcm13010238.

112. Papamichail A, Kourek C, Briasoulis A, Xanthopoulos A, Tsougos E, Farmakis D, Paraskevaidis I. Targeting key inflammatory mechanisms underlying in heart failure: a

comprehensive review. Int J Mol Sci. 2023 Dec 29;25(1):510. doi: 10.3390/ijms25010510.

113. Androulakis E, Kourek C, Vrettos A, Kontopodis N, Lioudaki E, Prasinou M, Xanthopoulos A, Antonopoulos A, Briasoulis A, Mohiaddin R. Assessment of extra-coronary peripheral arteriopathy in spontaneous coronary dissection; State of the art in non-invasive imaging techniques and future perspectives. European Heart Journal-Imaging Methods and Practice. September 2023; 1(2): qyad044. https://doi.org/10.1093/ehjimp/qyad044

114. Gemelli M, Doulamis IP, Tzani A, Rempakos A, Kampaktsis P, Alvarez P, Guariento A, Xanthopoulos A, Giamouzis G, Spiliopoulos K, Asleh R, Duque ER, and Briasoulis A. Rejection Requiring Treatment within the First Year Following Heart Transplantation: The UNOS Insight. J. Pers. Med. 2024;14(1):52 https://doi.org/10.3390/jpm14010052

115. Magouliotis DE, Xanthopoulos A, Athanasiou T. Y-incision aortic annular enlargement and the golden ratio: Nature leads the way. J Thorac Cardiovasc Surg. 2024 Feb 7:S0022-5223(24)00025-4. doi: 10.1016/j.jtcvs.2024.01.012.

116. Kourtis K, Bourazana A, Xanthopoulos A, Skoularigkis S, Papadakis E, Patsilinakos S, Skoularigis J. Association between ranolazine, ischemic preconditioning and cardioprotection in patients undergoing scheduled percutaneous coronary intervention. Medicina (Kaunas). 2024 Jan 16;60(1):166. doi: 10.3390/medicina60010166.

117. Theodorakopoulou MP, Alexandrou M-E, Tsitouridis A, Kamperidis V, Pella E, Xanthopoulos A, Ziakas A, Triposkiadis F, Vassilikos V, Papagianni A, Sarafidis P. Effects of sodium-glucose co-transporter 2 inhibitors on heart failure events in chronic kidney disease: a systematic review and meta-analysis. Eur Heart J Cardiovasc Pharmacother. 2024 Jan 13:pvae003. doi: 10.1093/ehjcvp/pvae003.

118. Bourazana A, Xanthopoulos A, Briasoulis A, Magouliotis D, Spiliopoulos K, Athanasiou T, Vassilopoulos G, Skoularigis J, Triposkiadis F. Artificial Intelligence in Heart Failure: Friend or Foe. Life (Basel). 2024 Jan 19;14(1):145. doi: 10.3390/life14010145.

119. Chrysakis N, Magouliotis DE, Spiliopoulos K, Athanasiou T, Briasoulis A, Triposkiadis F, Skoularigis J, Xanthopoulos A. Heart Transplantation. J Clin Med. 2024 Jan 18;13(2):558. doi: 10.3390/jcm13020558.

120. Triposkiadis F, Xanthopoulos A, Drakos SG, Boudoulas KD, Briasoulis A, Skoularigis J, Tsioufis K, Boudoulas H, Starling RC. Back to the Basics: The Need for an Etiological Classification of Chronic Heart Failure. Curr Probl Cardiol. 2024 Apr;49(4):102460. doi: 10.1016/j.cpcardiol.2024.102460.

121. Abbasciano R, Magouliotis DE, Koulouroudias M, Spiliopoulos K, Xanthopoulos A, Kourliouros A, Casula R, Athanasiou T, Viviano A. Valve type and operative risks in surgical explantation of transcatheter aortic valves: a systematic review and meta-analysis. J. Clin. Med. 2024; 13(5):1262 https://doi.org/10.3390/jcm13051262.

122. Spiliopoulos K, Magouliotis DM, Xanthopoulos A, Athanasiou T, Skoularigis J. Surgical AVR in patients aged <50y and the choice of the prosthesis used: Revisiting the established practice based on convincing evidence or upon “comparing apples to oranges”? Eur J Cardiothorac Surg. 2024 Mar 1;65(3):ezae067. doi: 10.1093/ejcts/ezae067.

123. Kourek C, Briasoulis A, Magouliotis DE, Skoularigis J, Xanthopoulos A. Latest updates on the structure and the recommendations of cardiac rehabilitations programs in chronic heart failure. World J Clin Cases. 2024 March 16; 12(8): 1382-1387. doi: 10.12998/wjcc.v12.i8.1382

124. Kourek C, Briasoulis A, Papamichail A, Xanthopoulos A, Tsougos E, Farmakis D, Paraskevaidis I. Beyond quadruple therapy in Heart Failure with reduced Ejection Fraction: Medical therapies with potential to become part of the therapeutic armamentarium. Int. J. Mol. Sci. 2024; 25(6): 3113. https://doi.org/10.3390/ijms25063113

125. Spiliopoulos K, Magouliotis D, Athanasiou T, Skoularigis J, Xanthopoulos AV.

Trends, Implications and Outcomes in the Changing Landscape of Cardiac Surgery: Transcatheter Aortic Valve Implantation in Patients with Severe Aortic Stenosis and Concomitant Coronary Artery Disease. Braz J Cardiovasc Surg. 2024. Accepted for publication.

126. Magouliotis DE, Tatsios E, Giamouzis G, Samara AA, Xanthopoulos A, Briasoulis A, Skoularigis J, Athanasiou T, Bareka M, Kourek C, Zacharoulis D. Validation of perioperative Troponin levels for predicting postoperative mortality and long-term survival in patients with hepatobiliary and pancreatic cancer undergoing surgery. J. Cardiovasc. Dev. Dis. 2024;11(4):130 https://doi.org/10.3390/jcdd11040130

127. Papagiannis D, Kourek C, Briasoulis A, Fradelos EC, Papagianni ED, Papadimopoulos I, Giamouzis G, Skoularigis J, Xanthopoulos A. Pneumococcal and influenza vaccination coverage in patients with heart failure: A systematic review. J Clin Med. 2024 May 21;13(11):3029. doi: 10.3390/jcm13113029.

128. Xanthopoulos A, Katsiadas N, Giamouzis G, Vangelakou K, Balaskas D, Papamichalis M, Bourazana A, Chrysakis N, Kiokas S, Kourek C, Briasoulis A, Niki Skopeliti, Makaritsis KP, Parissis J, Stefanidis I, Magouliotis D, Athanasiou T, Triposkiadis F, Skoularigis J. Contemporary use of sodium glucose co-transporter 2 inhibitors in hospitalized heart failure patients: a “real-world” experience. J. Clin. Med. 2024 Jun 18;13(12):3562. doi: 10.3390/jcm13123562.

129. Rad AA, Tserioti E, Magouliotis DE, Vardanyan R, Samiotis IV, Skoularigis J, Ariff B, Xanthopoulos A, Triposkiadis F, Casula R, Athanasiou T. Assessment of Myocardial Viability in Ischemic Cardiomyopathy with Reduced Left Ventricular Function Undergoing Coronary Artery Bypass Grafting. Clin Cardiol. 2024 Jul;47(7):e24307. doi: 10.1002/clc.24307.

130. Kourek C, Briasoulis A, Magouliotis DE, Georgoulias P, Giamouzis G, Triposkiadis F, Skoularigis J and Xanthopoulos A. Recent advances in the diagnostic methods and therapeutic strategies of transthyretin cardiac amyloidosis. World J Cardiol. 2024 Jul 26;16(7):370-379. doi: 10.4330/wjc.v16.i7.370.

131. Sotiropoulou IM, Manetas-Stavrakakis N, Kourek C, Xanthopoulos A, Magouliotis D, Giamouzis G, Skoularigis J, Briasoulis. A.Prevention of Anthracycline or HER2 Inhibitor induced Cardiotoxicity: A Systematic Review and Meta-Analysis. Cancers. 2024;16(13):2419 https://doi.org/10.3390/cancers16132419

132. Magouliotis DE, Sicouri S, Baudo M, Yamashita Y, Xanthopoulos A, Arjomandi Rad A, Athanasiou T, Ramlawi B. Transthoracic cross clamp versus endoaortic balloon occlusion in minimally invasive mitral valve surgery: A pooled study with subgroup analyses. J Clin Med. 2024 Aug 23;13(17):4989. doi: 10.3390/jcm13174989.

133. Kourek C, Xanthopoulos A, Giamouzis G, Parisis C, Briasoulis A, Magouliotis DE, Triposkiadis F, Skoularigis J. Neurohormonal effects of intravenous dopamine in patients with acute heart failure. J Clin Med. 2024 Sep 24;13(19):5667. doi: 10.3390/jcm13195667

134. Magouliotis DE, Rad AA, Viviano A, Oo AY, Xanthopoulos A, Sicouri S, Ramlawi B, Athanasiou T. Hemostatic properties of aortic root preservation versus root

replacement for acute type A aortic dissection: a pooled analysis. Life (Basel). 2024 Oct 1;14(10):1255. doi: 10.3390/life14101255.

135. Triposkiadis F, Xanthopoulos A, Skoularigis J. Targeting sodium in heart failure. J. Pers. Med. 2024;14(10):1064 https://doi.org/10.3390/jpm14101064

136. Magouliotis DE, Giamouzis G, Athanasiou T, Spiliopoulos K, Briasoulis A, Skoularigis J, Triposkiadis F, Xanthopoulos A. Pooled comparative analysis of transcatheter aortic valve replacement versus surgical aortic valve replacement in patients with left ventricular assist device. Gen Thorac Cardiovasc Surg. 2024 Oct 26. doi: 10.1007/s11748-024-02100-3. Online ahead of print.

137. Zakynthinos GE, Tsolaki V, Xanthopoulos A, Karavidas N, Vazgiourakis V, Bardaka F, Giamouzis G, Pantazopoulos I, Makris D. Prevalence, Risk Factors and Mortality of New Onset Atrial Fibrillation in mechanically ventilated Critically Ill Patients. J Clin Med. 2024 Nov 9;13(22):6750. doi: 10.3390/jcm13226750.

138. Spiliopoulos K, Xanthopoulos AV, Sideris K, Magouliotis D, Skoularigis J. Implications for prosthesis selection in dialysis patients undergoing aortic valve replacement. Gen Thorac Cardiovasc Surg. 2024 Nov 13. doi: 10.1007/s11748-024-02104-z. Online ahead of print.

139. Triposkiadis F, Briasoulis A, Xanthopoulos A. Amyloids and the Heart: An Update. J Clin Med. 2024 Nov 27;13(23):7210. doi: 10.3390/jcm13237210.

140. Zakynthinos GE, Gialamas I, Tsolaki V, Pantelidis P, Goliopoulou A, Gounaridi MI, Tzima I, Xanthopoulos A, Kalogeras K, Siasos G, Oikonomou E. Tailored Therapies for Cardiogenic Shock in Hypertrophic Cardiomyopathy: Navigating Emerging Strategies. J. Cardiovasc. Dev. Dis. 2024; 11(12): 401. https://doi.org/10.3390/jcdd11120401

141. Zakynthinos GE, Tsolaki V, Mantzarlis K, Xanthopoulos A, Oikonomou E, Kalogeras K, Siasos G, Vavuranakis M, Makris D, Zakynthinos E. Navigating Heart-Lung Interactions in Mechanical Ventilation: Pathophysiology, Monitoring, and Advanced Management Strategies. J. Clin. Med. 2024; 13(24): 7788 https://doi.org/10.3390/jcm13247788
Τμήμα: ΠΜΣ «Θρόμβωση και την Αντιθρομβωτική Αγωγή»
Περιγραφή: Επίκουρος Καθηγητής